Jyong Biotech Ltd. (MENS)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $1.80
- As of
Kresmion compiles this page from MENS's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Jyong Biotech Ltd. (MENS): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 20-F filed 2026-05-15.
See the full MENS dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for MENS on one page. Preview it with sample data, then open it live with a free account.
Preview the MENS dossierActive events for MENS
- medium13F: new position
RENAISSANCE TECHNOLOGIES LLC new position in MENS
- high13F: large reduction
MILLENNIUM MANAGEMENT LLC cut 64% of MENS (2026Q1)
FREE, NO ACCOUNT
Every event on MENS, as it fires
New filings, 13F moves and cross asset events on MENS land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
MENS positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC FundCUSIP G83116106 · 2026Q2 | $47K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, MENS
- 20-FSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
Going concern statement
MENS's 20-F filed May 15, 2026 states:
As such, we concluded that there is substantial doubt about our ability to continue as a going concern within one year after the issuance date of the consolidated financial statements.
Read the 20-F on SEC EDGAR Every company with a going concern statement
More data on MENS
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in MENS on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on MENS in the last 180 days.
Upstream: SEC EDGAR filings for MENS
Kresmion, "Jyong Biotech Ltd. (MENS) institutional holdings and SEC filings", data as of 2026-08-16, https://kresmion.com/research/MENS. Upstream data: SEC EDGAR filings for MENS.
Link to this data (HTML):
<a href="https://kresmion.com/research/MENS">Jyong Biotech Ltd. (MENS) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow MENS on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to MENS for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.